Fig. 2From: Mingjing granule, a traditional Chinese medicine in the treatment of neovascular age-related macular degeneration: study protocol for a randomized controlled trialStudy schedule. BCVA, best-corrected visual acuity; CRT, central retinal thickness; PRN, pro re nata. Ranibizumab will be administered as needed after three consecutive monthly injections (3 + PRN)Back to article page